Browsing by Author Saltz, Leonard B.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)Citation
2008Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III studyClarke, Stephen; Diaz-Rubio, Eduardo; et, al; Figer, Arie; Koski, Sherryl; Lichinitser, Mikhail; Rivera, Fernando; Saltz, Leonard B.; Scheithauer, Werner; Wong, Ralph; Yang, Tsai-Shen; Northern Clinical School: Kolling InstituteBevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study, Journal of Clinical Oncology, vol.26, 12, 2008,pp 2013-2019
2008Potential regional differences for the tolerability profiles of fluoropyrimidinesClarke, Stephen; Allegra, C; Cassidy, J; Cunningham, David; et al, not known; Haller, D M; Hoff, P; Rothenberg, M; Saltz, Leonard B.; Concord Clinical School: ANZAC Research InstitutePotential regional differences for the tolerability profiles of fluoropyrimidines, Journal of Clinical Oncology, vol.26,(13),2008,pp 2118-2123
2016Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) databaseTebbutt, Niall; Adams, Richard; et al, Various; Franko, Jan; Koopman, Miriam; Maughan, Timothy; Meyers, Jeffrey; Punt, Cornelis JA; Saltz, Leonard B.; Seymour, Matthew; Shi, Qian; NH&MRC Clinical Trials CentrePrognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database, The Lancet Oncology, vol.17, 12, 2016,pp 1709-1719
2011XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated resultsClarke, Stephen; Cassidy, J; Diaz-Rubio, E; Figer, A; Gilberg, F; Koski, S; Rittweger, K; Saltz, Leonard B.; Scheithauer, W; Wong, R; Northern Clinical School: Kolling InstituteXELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results, British Journal of Cancer, vol.105, 1 Spring 2010, 2011,pp 58-64